Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/17863
Title: Combined BRAF and MEK inhibition in BRAF-mutant NSCLC.
Authors: Rivalland, Gareth;Mitchell, Paul L R
Affiliation: Department of Medical Oncology, Austin Health, Olivia Newton-John Cancer Wellness & Research Centre, Heidelberg, Victoria, Australia
University of Melbourne, VIC, Australia
Thoracic Alliance for Cancer Trials, Milton, QLD, Australia
Issue Date: Jul-2016
EDate: 2016-06-06
Citation: Lancet Oncology 2016; 17(7): 860-862
URI: http://ahro.austin.org.au/austinjspui/handle/1/17863
DOI: 10.1016/S1470-2045(16)30203-0
PubMed URL: 27283865
Type: Journal Article
Comment
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.